New Study Raises Concerns About Additional Roundup Cancer

All around the United States, victims of Roundup cancer are assessing the terms of a proposed settlement that the herbicide’s owner, Bayer AG, has offered to victims. But even as the company works to ensure that it will be able to continue selling their product without warnings of its carcinogenic nature, new studies are being conducted and published, suggesting that glyphosate-based products are responsible for even more damage. The most recent of these suggests that the chemical may be damaging reproductive organs and fertility.

As if concerns about Roundup cancer were not enough to raise consumer concerns, a new study published in last month’s issue of Molecular and Cellular Endocrinology reported that exposure to the active ingredient in the weed killer might be interfering with hormones, including those that are essential to both development and reproductive health. Other impacts of the chemical may impact the brain and immune system. The researchers explicitly indicate that their studies place into question the U.S. Environmental Protection Agency’s conclusions about the product’s safety.

Is Roundup Cancer the Tip of the Iceberg for Safety Concerns About the Product?

The ongoing litigation surrounding Roundup cancer accuses the product’s manufacturer of malfeasance in its presentation of the product. Many of those who have been diagnosed with non-Hodgkin lymphoma after using the product accuse Monsanto, the company’s manufacturer, of purposely misleading the public and health officials about its risks, and there have been more than 100,000 claims filed against Monsanto’s new owner, Bayer AG.

Of particular concern are the recent questions about whether Roundup cancer is strictly a risk for those who actively use the product or whether it may cause trouble for those exposed to produce and water that it has impacted. Glyphosate has been found in human urine, and though many believe that only high level exposure to glyphosate presents a health risk, the new study shows that low dose exposure can also affect female fertility.

Author: Terri Oppenheimer

Terri Oppenheimer

Terri Oppenheimer is an independent writer, editor, and proofreader. She graduated from the College of William and Mary with a degree in English. She specializes in providing content for websites and finds tremendous enjoyment in the things she learns while doing her research. Her specific areas of interest include health and fitness, medical research, and the law.